| __timestamp | Iovance Biotherapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 1488000000 |
| Thursday, January 1, 2015 | 15470000 | 1525000000 |
| Friday, January 1, 2016 | 28037000 | 2111000000 |
| Sunday, January 1, 2017 | 71615000 | 1848000000 |
| Monday, January 1, 2018 | 99828000 | 1213000000 |
| Tuesday, January 1, 2019 | 166023000 | 1010000000 |
| Wednesday, January 1, 2020 | 201727000 | 997000000 |
| Friday, January 1, 2021 | 259039000 | 967000000 |
| Saturday, January 1, 2022 | 294781000 | 838000000 |
| Sunday, January 1, 2023 | 344077000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
In pursuit of knowledge
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Iovance Biotherapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
Teva, a global leader in generic and specialty medicines, has consistently invested in R&D, with expenses peaking in 2016. Despite a 60% reduction in spending from 2016 to 2022, Teva's commitment to innovation remains evident.
Conversely, Iovance, a pioneer in cell therapy, has seen a remarkable 127-fold increase in R&D expenses from 2014 to 2023. This surge underscores Iovance's aggressive pursuit of cutting-edge therapies.
As the pharmaceutical industry continues to innovate, these trends highlight the diverse strategies companies employ to stay at the forefront of medical advancements.
R&D Insights: How Johnson & Johnson and Iovance Biotherapeutics, Inc. Allocate Funds
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
Sanofi vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
R&D Insights: How Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited Allocate Funds
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Mesoblast Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Geron Corporation or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Iovance Biotherapeutics, Inc. and Celldex Therapeutics, Inc.